Description: Taj Pharma India is Best Known Manufacturer, Exporter and Supplier Epalrestat Tablets (EPATAJ) from Vapi, Gujarat India. Adherence to antidiabetic therapy can delay the onset of or prevent diabetic nerve disease. If you have existing diabetic nerve disease, wear proper footwear and examine your feet every day to detect lesions early. If you have a foot injury or open wound, avoid engaging in weight-bearing activities.We are a trusted manufacturer, exporter, and supplier of Epalrestat Sustained Release Tablets 150mg (EPATAJ) in India, offering advanced pharmaceutical solutions for the management of diabetic neuropathy. Epalrestat is an aldose reductase inhibitor that helps reduce sorbitol buildup in nerve tissues, a major cause of diabetic nerve damage. By controlling this pathway, it effectively helps relieve symptoms such as burning pain, tingling, numbness, and nerve discomfort. Our Epalrestat 150mg sustained release tablets are formulated using modern pharmaceutical technology to ensure controlled and prolonged drug release. This enhances therapeutic efficiency, improves patient adherence, and provides consistent symptom relief with convenient once-daily dosing. Manufactured in a WHO-GMP certified facility in Vapi, Gujarat, India, each batch undergoes strict quality testing to ensure high purity, safety, and stability. We supply Epalrestat Tablets 150mg to international markets including Africa, the Middle East, and Latin America (LATAM), serving distributors, wholesalers, and healthcare institutions with reliable and cost-effective diabetic care products. Our strong export network ensures smooth global supply and timely delivery. We also offer PCD Pharma Franchise opportunities, enabling business partners to grow in the high-demand diabetic therapeutic segment with strong market support and brand value. With a focus on innovation, quality assurance, and global healthcare excellence, we continue to strengthen our position as a leading pharmaceutical manufacturer and exporter of Epalrestat Sustained Release Tablets 150mg, improving diabetic neuropathy treatment outcomes worldwide.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 175 KB
